ReviewParasites & vectors2017
A review of Sarcoptes scabiei: past, present and future.
Review in Parasites & vectors, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 166 papers, 6 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
166 citing papers in PubMed, 6 syntheses or guidelines pooled it, 355 citations in OpenAlex.
- Pooled it
- Efficacy and safety of oral ivermectin versus benzyl benzoate for the treatment of scabies: a systematic review and meta-analysis of randomized controlled trials.Frontiers in medicine · 2025Pooled it
- Global prevalence and predictors of scabies among prisoners: systematic review and meta-analysis.BMC public health · 2024Pooled it
- Evidence underscoring immunological and clinical pathological changes associated with Sarcoptes scabiei infection: synthesis and meta-analysis.BMC infectious diseases · 2022Pooled it
- Do we know how scabies outbreaks in residential and nursing care homes for the elderly should be managed? A systematic review of interventions using a novel approach to assess evidence quality.Epidemiology and infection · 2019Pooled it
- A systematic review of scabies transmission models and data to evaluate the cost-effectiveness of scabies interventions.PLoS neglected tropical diseases · 2019Pooled it
- Oral ivermectin versus 5% permethrin cream to treat children and adults with classic scabies: multicentre, assessor blinded, cluster randomised clinical trial.BMJ (Clinical research ed.) · 2026Trial
- Skin Health Literacy in Ontario Secondary Schools: An Overlooked Opportunity for Preventive Health Education.The Journal of school health · 2026Article
- The Impact of Steroid Use on Scabies Treatment: An Evaluation of Clinical Severity, Parasite Burden, and the Validity of a Novel Scoring System.International journal of dermatology · 2026Article
- Pharmacokinetics of Moxidectin in Bare-Nosed Wombats (Vombatus ursinus) After Intravenous, Sub-Cutaneous and Transdermal Administration.Journal of veterinary pharmacology and therapeutics · 2026Article
- A Case-Control Study of Risk Factors for Scabies Among Patients Attending Dermatology Clinics in Afghanistan.Health science reports · 2026Article
- Clinical features of 170 Chinese scabies cases and the therapeutic efficacy of sulfur ointment.PLoS neglected tropical diseases · 2026Article
- A LAMP-based assay for rapid detection of human scabies using clinical skin scraping specimens.Scientific reports · 2026Article
- Article
- Observational
- Serological survey on Sarcoptes scabiei var. suis in fattening pigs and sows from intensive farms in Italy.Parasitology research · 2026Article
- Evaluating Punica granatum mediated AgNPs acaricidal activity against Rhipicephalus microplus and Sarcoptes scabiei using in vitro and in silico analyses.Scientific reports · 2026Article
- Article
- Human scabies and pediculosis in Ecuador: spatial distribution and environmental determinants.Parasitology · 2026Article
- Article
106 more citing papers are in PubMed but not listed here.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors at 1 institution in 1 country.
Funding
Abstract
The disease scabies is one of the earliest diseases of humans for which the cause was known. It is caused by the mite, Sarcoptes scabiei, that burrows in the epidermis of the skin of humans and many other mammals. This mite was previously known as Acarus scabiei DeGeer, 1778 before the genus Sarcoptes was established (Latreille 1802) and it became S. scabiei. Research during the last 40 years has tremendously increased insight into the mite's biology, parasite-host interactions, and the mechanisms it uses to evade the host's defenses. This review highlights some of the major advancements of our knowledge of the mite's biology, genome, proteome, and immunomodulating abilities all of which provide a basis for control of the disease. Advances toward the development of a diagnostic blood test to detect a scabies infection and a vaccine to protect susceptible populations from becoming infected, or at least limiting the transmission of the disease, are also presented.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.